Since a synergistic effect between inhibitors of histone deacetylation and DNA methylation has been observed in cancer cells [62], [63], it is quite possible that demethylation combined with HDAC inhibition may lead to even greater neuroprotection in models of retinopathy. The gene discussed is HDAC9; the disease is cancer.